UBS Group AG Lowers Holdings in Zepp Health Corporation Sponsored ADR $ZEPP

UBS Group AG decreased its stake in Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) by 45.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 98,217 shares of the company’s stock after selling 83,085 shares during the quarter. UBS Group AG owned approximately 0.68% of Zepp Health worth $2,646,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of ZEPP. Trivest Advisors Ltd purchased a new stake in shares of Zepp Health in the third quarter worth about $13,503,000. Millennium Management LLC purchased a new stake in shares of Zepp Health in the third quarter worth about $11,265,000. Keystone Investors PTE Ltd. purchased a new stake in shares of Zepp Health in the third quarter worth about $4,811,000. Lighthouse Investment Partners LLC purchased a new stake in shares of Zepp Health in the third quarter worth about $2,070,000. Finally, Harvest Fund Management Co. Ltd purchased a new stake in shares of Zepp Health in the third quarter worth about $1,895,000. Hedge funds and other institutional investors own 52.61% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Fundamental Research set a $56.28 target price on Zepp Health and gave the stock a “buy” rating in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $56.28.

Zepp Health Price Performance

Shares of Zepp Health stock opened at $8.86 on Wednesday. The business has a 50 day simple moving average of $13.17 and a two-hundred day simple moving average of $20.54. Zepp Health Corporation Sponsored ADR has a 12 month low of $2.25 and a 12 month high of $61.85. The stock has a market capitalization of $130.06 million, a P/E ratio of -3.53 and a beta of 2.00. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.02 and a quick ratio of 0.77.

Zepp Health Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.